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Introduction
Over the past decade a number of changes have occurred in European Union chemicals policy that have led to an increase in efforts to develop alternative methods to traditional animal testing for risk assessment. 1=7 These alternatives have been developed employing , and methods focussing on replacing or reducing animals used in short=term toxicity tests 8 . In order to be relevant, and useful, for regulatory assessment these alternatives should be based upon specific endpoints. Within recent years, interest has grown in developing a greater understanding of toxicity pathways. One such pathway approach is the Adverse Outcome Pathway (AOP) paradigm. An AOP is a framework that means to establish a mechanistic connection between an upstream Molecular Initiating Event (MIE) and a downstream adverse outcome relevant for risk assessment.
9=12
The MIE is the critical event in the progression of an AOP as it provides insight into the initial interaction(s) between the chemical behaviour of the xenobiotic and the biological system that initiates the perturbation of the normal pathway. Elucidation of the mechanistic information relating to specific MIEs enables the identification of structural (and physico= chemical) features of chemicals that are responsible for the interaction with biological macromolecules, thus, facilitating the development of structural alerts. When utilised together, multiple structural alerts pertaining to the same MIE form the basis of an profiler.
13=
16 The information within an profiler can, in turn, be used to develop chemical categories centred on a common MIE (note that multiple MIEs can be initiated by a single chemical). This allows for read=across and data gap filling to be applied. The premise behind these structurally developed categories is that similar chemicals should have similar biological activities and therefore, should have the same MIE. Furthermore, the categories produced using profilers can be supported by, and used to prioritise, additional 5 testing using and/or methods, within an integrated testing strategy. Such strategies can be used for hazard identification and risk assessment purposes, as well as being incorporated into software tools such as the OECD QSAR Toolbox.
10=11, 16=18
A number of profilers have been developed for a variety of organ=level toxicities, such as skin sensitisation, respiratory sensitisation, genotoxicityand hepatotoxicity. 13=15, 19=21 However, very few profilers have dealt with toxicity induced by mitochondrial dysfunction. 1, 22, 23 This is, in part, due to the number of mechanisms by which a chemical could induce mitochondrial dysfunction 24 . An additional complication is that a single chemical might have the ability to induce more than one of these mechanisms, making it difficult to define a single MIE within the AOP paradigm. Over the past decade, interest in screening chemicals for an ability to induce mitochondrial dysfunction has increased. 24, 25 This is, in part, due to the withdrawal of a number of pharmaceuticals from the market after observed mitochondrial dysfunctions. 26=31 Toxicity to mitochondria has led to such withdrawals as these are important organelles present within almost every cell type of the body, the exception being mature erythrocytes. 32, 33 The basic structure and function of mitochondria consists of two membranes, the outer and inner membrane, enclosing three compartments, the inter membrane space, the cristae and the mitochondrial matrix. The outer membrane is relatively smooth and permeable to molecules that are less than 5kDa in size. In contrast, the inner membrane contains multiple invaginations (cristae), is impermeable to all molecules except O 2 , CO 2 , and H 2 O and contains each of the protein complexes within the electron transport chain, ATP synthase (Complex V) and various electron carriers. The mitochondria are responsible for a number of tasks vital to a cell's normal functioning and survival. These tasks include the production of approximately 95% of the total amount of Adenosine Tri=Phosphate (ATP) generated by cells during oxidative phosphorylation.
Oxidative phosphorylation is a process whereby energy from the transfer of electrons, 6 generated by the oxidation of Nicotinamide Adenine Dinucleotide (NADH) and Flavin Adenine Dinucleotide (FADH 2 ), along various complexes of the electron transport chain is used to pump protons across the inner mitochondrial membrane generating an electrochemical gradient. The electron transport chain comprises four complexes situated within the inner mitochondrial membrane. Complexes I and II are involved in the oxidation of NADH and FADH 2 respectively, providing the input of electrons into the respiratory chain.
Complexes I, III and IV use the energy released from the transfer of electrons along the electron transport chain to pump protons out of the mitochondrial matrix into the inter membrane space. 25, 31, 34 Complex V, the terminal complex involved in oxidative phosphorylation, utilises the electrochemical gradient produced to transfer protons from the inter membrane space back into the mitochondrial matrix. The energy released from this action is used to phosphorylate adenosine diphosphate into ATP.
Previous research has shown that mitochondrial dysfunction may be induced by a range of chemicals and has been linked to a variety of organ toxicities within kidney, liver and nervous tissues. 26=31,35 The most susceptible tissues to mitochondrial dysfunction are those containing a higher concentration of mitochondria or those exposed to a higher Given the importance of mitochondria within most cell systems, and the wide range of organ=level toxicities that may arise from mitochondrial dysfunction, the aim of the study was to identify structural alerts that could be used to form an profiler suitable for grouping chemicals into mechanism=based categories. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 anaesthetics, can also act to uncouple oxidative phosphorylation via the mechanism outlined above without the need to complex with a lipophilic anion. 49 The presence, and pKa, of the tertiary amine group is thought to be responsible for the ability of these chemicals to scavenge protons within the inner membrane space. Therefore, the lack of a tertiary amine group offers an explanation as to why no mitochondrial toxicity has been associated with tocainide.
Category 2: anti=diabetic drugs
This category consists of three thiazolidinediones: pioglitazone, rosiglitazone, troglitazone: each of which were identified as inducing mitochondrial toxicity.
Thiazolidinediones are the major orally administered drugs used in the treatment of Type 2 (non=insulin dependent) diabetes. These drugs are used to improve insulin sensitivity and Additionally, thiazolidinediones have been shown to uncouple oxidative phosphorylation in a manner similar to that described above for the chemicals within category one. 22, 26 It is thought that the properties that enable the thiazolidinediones to bind to the nuclear PPAR= gamma receptor confers the ability to bind to Complex I. 26 Additionally, the heterocyclic properties of the ring system are thought to enable the thiazolidinedione to cycle between a protonated and deprotonated form conferring the ability to transport protons across the inner mitochondrial membrane thereby uncoupling oxidative phosphorylation.
Category 3: Nonsteroidal anti=inflammatory drugs
The third category comprises three chemicals: mefenamic acid, flufenamic acid, and tolfenamic acid: each of which has been identified as being able to induce mitochondrial toxicity. Each of these three chemicals are part of a group of nonsteroidal anti=inflammatory (NSAIDs). NSAIDs are some of the most widely used pharmaceutical drugs on the market that are used for their analgesic, antipyretic and anti=inflammatory properties to reduce and relieve symptoms for a variety of conditions. In order for the anti=inflammatory properties associated with NSAIDs to be present a carboxylic acid moiety is needed.
51
. The carboxylic acid moiety acts to inhibit cyclooxygenase activity, an enzyme responsible for the production as having the ability to uncouple oxidative phosphorylation via a similar mechanism as that described above for the lidocaine category. 56=60 However, due to their lipophilicity, these chemicals do not necessarily need to be associated with a separate hydrophobic anion in order to translocate into the mitochondrial matrix. The carboxylic acid moiety, which is required for the anti=inflammatory properties of the NSAIDs, is believed to also be required to induce the uncoupling ability of this group of chemicals. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 14 action is conserved throughout the category. It should also be noted that quinones are also used as antimalarials which are known mitochondrial toxicants. Perfluorooctane sulphonamide has been shown to uncouple oxidative phosphorylation via a protonophoric mechanism, similar to that described above, within various species 23,67=69
. In comparison to =trifluromethoxyphenylhydrazone, one of the most potent uncouplers, perfluorooctane sulphonamide has been known to uncouple oxidative phosphorylation with a potency of a similar magnitude. It has been suggested that the pKa and ionisability of the amino acid moiety, in conjunction with the relatively high lipophilicity of the chemical, enables the shuttling of protons across the inner mitochondrial membrane into the matrix, dissipating the membrane potential. 69 Starkov studied the structural activity of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 perfluoroalkanes and their ability to elicit mitochondrial toxicity via disruption to oxidative phosphorylation. 69 Their data identified that a protonated nitrogen atom with a favourable pKa is essential to the uncoupling action of perfluorooctane sulphonamides in mitochondria.
In addition, perfluorooctane sulphonamide is one of a very limited number of uncoupling chemicals that does not contain a ring structure 68 . In contrast, the perfluoroalkyl acids are believed to induce the mitochondrial membrane permeability transition at lower concentrations, whilst higher concentrations can uncouple oxidative phosphorylation 69=71 . It has been observed that perfluorodecanoic acid forms reactive oxygen species (ROS), hydrogen peroxide and peroxynitrite anion. 72 The presence of elevated ROS levels initiates oxidative stress within mitochondria. Oxidative stress has been shown to induce the membrane permeability transition (MPT). 73, 74 The MPT is an increase in permeability of the inner mitochondrial membrane to low molecular weight solutes (<1500 Daltons). The subsequent influx of solutes into the matrix instigates swelling of the inner and outer membranes causing disruption of the electron transport chain and a release of apoptotic proteins such as cytochrome c. 23, 72, 75 The uncoupling action of the two perfluoroalkyl acids is similar to that described for category one. Two alerts were defined due to two distinct MIEs being identified (Table 2) . Previous research has shown there to be an increase in toxicity concomitant to an increase in alkyl side chain length up to C 12 , with the most marked increase in toxicity (a five= to ten= fold increase) occurring between C 6 and C 8 perfluoroalkyl acids and sulphates. 23 An unsubstituted amide fragment has been shown to be required in order for uncoupling by perfluorinated sulphonamides to occur: fully substituted sulphonamides, which lack the protonated amide moiety, were found to lack the ability to uncouple oxidative phosphorylation. 69 The carboxylic acid moiety of the perfluoroalkyl acids chemicals is thought to be responsible for the uncoupling action of these chemicals at higher 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   16 concentrations. However, it is unclear which fragments are required in the induction of the MPT. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Work carried out within Terada demonstrated that an acid dissociable group, bulky hydrophobic moiety and strong electron=withdrawing group are essential for the induction of uncoupling this conclusion can support why this class of drugs may act as uncouplers.
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Based upon information in the literature both the tertiary amine moiety and the phenothiazine fragment with an associated electron=withdrawing group are required in order to initiate uncoupling of oxidative phosphorylation.
Category 8: β=blockers
Alprenolol, propranolol and atenolol are a group of (non=)selective β=blockers used in the treatment of hypertension. As can be seen in Table 1 97 Further research into how propranolol and atenolol is required in order to establish a clear structure=activity relationship for these structurally similar, β=blockers, given that they appear to have differing mechanisms of mitochondrial toxicity.
The ability to predict organ=level toxicity will become increasingly important to the long term goal of replacing animal use in determining a Lowest Observed (Adverse) Effect
Level (LO(A)EL). Traditionally, LO(A)ELs are identified after undertaking a 28= or 90=day
repeated dose study, with the lowest dose initiating a treatment related adverse effect in an organ(s) producing the LO(A)EL value. However, as no animal testing is permissible for cosmetic ingredients in Europe alternatives are required. As discussed previously this has led to increased interest in the understanding of toxicity pathways and in the development of
AOPs. As such the structural alerts that have been developed in this study are intended for use in chemical risk assessment within the AOP paradigm. Within the AOP paradigm one of the roles of computational toxicology is to define the chemistry associated with key MIEs as an profiler. To this end the mechanistic chemistry outlined in the current study was combined with that previously published by Naven enabling 17 structural alerts to be defined ( Table 2) . 22 Briefly, Naven and co=workers analysed a database of more than 2000 compounds resulting in the identification of eleven structural alerts associated with the uncoupling of oxidative phosphorylation (which was defined by an increase in basal respiration). The two sets of structural alerts are, in the most part, complimentary with only the thiazolinedione alert being identified in both studies. In addition, the majority of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 22
Recently the development of AOPs has become an integral part of 21 st century toxicology, with the availability of the OECD AOP knowledgebase making AOP development a worldwide focus. 99 In order for mitochondria=mediated AOPs to be developed, further investigation into the organ(s) affected is required; this was, however, beyond the scope of the current study. The main outcome from the current study is that the structural alerts defined enable chemicals to be grouped into mechanistically=based categories based around the knowledge of a number of key MIEs for mitochondrial toxicity. The resulting categories can thus be used for either prioritisation of chemicals for further testing or, where sufficient data exist, for read=across predictions of organ=level toxicity (from, for example, repeat dose toxicity testing). In terms of predicting organ=level toxicity in the future it is likely that additional steps in the AOP will need to be investigated within assays using a range of organ specific cell lines. For example, the use of primary human renal proximal tubule epithelial cells in the MTT assays to investigate nephrotoxicity due to mitochondrial dysfunction. This will enable a mechanistically=based weight of evidence to be constructed based around the AOP and allow the formation of AOPs based on mitochondrial dysfunction. Currently, chemistry=based grouping methods such as those outlined above offer the most immediate solution to risk assessment without using animals.
Conclusions
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